At Long Term Support. Revenue Beat. 682% Upside.We are right at the support line spanning across 5 years. With revenue beat and 682% upside (average price target), it looks like a safe buy. I hold stocks and April 2025 calls.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.4089 USD
−82.47 M USD
7.38 M USD
225.46 M
About Vaxart, Inc. - Common Stock
Sector
Industry
CEO
Steven Lo
Website
Headquarters
South San Francisco
Founded
2004
FIGI
BBG000DR0RZ7
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in March 2004 and is headquartered in South San Francisco, CA.
Something's Got To BreakVXRT is at support currently after multiple earnings calls showing improvements in company funding and positioning.
It is currently touching lows in a range of .52-.58 for the 6th time this year, if it is unable to break support again I personally believe this will break to the upside back over $1.
Vaxart, Inc. A big thank you to all for helping me reach the 8k follower milestone..
On the above weekly chart price action has corrected over 90% since February 2020. A number of reasons now exist to be bullish, including:
1) You know why..
2) Price action confirms support on past resistance.
3) The support
VXRT Potential Breakout/Trend Reversal?Vaxart's previous run after COVID ended with a .30c gap down on the daily early June 2023, even so, once reaching previous low it ran up again. It has also shown much more promising earnings since the gap down. They have also ditched the Covid program to focus on norovirus and prolong cash runway in
Bounce off of a very long term support line.Bouncing off of a 4.5 year long support line.
Golden cross forming.
$VXRT to $55 this year?I do dowsing and sometimes I let my pendulum pick stocks. I also let it pick important dates for stocks or the market.
Way back in July of 2021 I I got this stock and it told me to check on it in January of 2023. I've been doing this awhile, but don't have a big record of instances this far out in t
VAXART by MOOKVaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission
Vaxart/ Pelosi has covidWell with the news in china of lockdown and the shares of mrna bought or options exercised at .99 cents lol and Nancy Pelosi has covid and im sure somewhere her husband is about to wrap up some mrna stock which really moves the covid market like spy does i can expect some target to be met in the upc
Vaxart could make a moveMost these void stocks are down and well covid is the new flu, mrna is over sold as well as vaxart and vaxart has a strong price target from where it's at now... will be adding these to my watch list as they could easily move quickly.
Covid Stocks look like a buy Mrna kind of gives it away for the smaller ones but this setup on vaxart can really run its oversold and has a price target of $13 nice little flag forming
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VXRT is 0.6078 USD — it has increased by 1.64% in the past 24 hours. Watch Vaxart, Inc. - Common Stock stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vaxart, Inc. - Common Stock stocks are traded under the ticker VXRT.
VXRT stock has fallen by −11.43% compared to the previous week, the month change is a −22.50% fall, over the last year Vaxart, Inc. - Common Stock has showed a −20.03% decrease.
We've gathered analysts' opinions on Vaxart, Inc. - Common Stock future price: according to them, VXRT price has a max estimate of 8.00 USD and a min estimate of 2.50 USD. Watch VXRT chart and read a more detailed Vaxart, Inc. - Common Stock stock forecast: see what analysts think of Vaxart, Inc. - Common Stock and suggest that you do with its stocks.
VXRT reached its all-time high on May 5, 2004 with the price of 1,181.5175 USD, and its all-time low was 0.2543 USD and was reached on Sep 25, 2019. View more price dynamics on VXRT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VXRT stock is 5.72% volatile and has beta coefficient of 2.71. Track Vaxart, Inc. - Common Stock stock price on the chart and check out the list of the most volatile stocks — is Vaxart, Inc. - Common Stock there?
Today Vaxart, Inc. - Common Stock has the market capitalization of 141.04 M, it has increased by 2.27% over the last week.
Yes, you can track Vaxart, Inc. - Common Stock financials in yearly and quarterly reports right on TradingView.
Vaxart, Inc. - Common Stock is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
VXRT earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.10 USD resulting in a 40.30% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Vaxart, Inc. - Common Stock earnings.
Vaxart, Inc. - Common Stock revenue for the last quarter amounts to 4.93 M USD, despite the estimated figure of 1.93 M USD. In the next quarter, revenue is expected to reach 20.78 M USD.
VXRT net income for the last quarter is −14.08 M USD, while the quarter before that showed −16.47 M USD of net income which accounts for 14.49% change. Track more Vaxart, Inc. - Common Stock financial stats to get the full picture.
No, VXRT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 125.00 employees. See our rating of the largest employees — is Vaxart, Inc. - Common Stock on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vaxart, Inc. - Common Stock EBITDA is −67.20 M USD, and current EBITDA margin is −1.07 K%. See more stats in Vaxart, Inc. - Common Stock financial statements.
Like other stocks, VXRT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vaxart, Inc. - Common Stock stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vaxart, Inc. - Common Stock technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vaxart, Inc. - Common Stock stock shows the sell signal. See more of Vaxart, Inc. - Common Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.